Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Return on Equity (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Return on Equity for 5 consecutive years, with 0.74% as the latest value for Q3 2021.

  • Quarterly Return on Equity rose 589.0% to 0.74% in Q3 2021 from the year-ago period, while the trailing twelve-month figure was 0.74% through Sep 2021, up 589.0% year-over-year, with the annual reading at 1.97% for FY2020, 45.0% up from the prior year.
  • Return on Equity for Q3 2021 was 0.74% at ENDRA Life Sciences, down from 0.67% in the prior quarter.
  • The five-year high for Return on Equity was 2.76% in Q1 2017, with the low at 13.11% in Q3 2018.
  • Average Return on Equity over 5 years is 3.22%, with a median of 2.23% recorded in 2020.
  • The sharpest move saw Return on Equity tumbled -1261bps in 2018, then skyrocketed 759bps in 2021.
  • Over 5 years, Return on Equity stood at 0.86% in 2017, then plummeted by -291bps to 3.38% in 2018, then decreased by -28bps to 4.32% in 2019, then surged by 48bps to 2.23% in 2020, then soared by 67bps to 0.74% in 2021.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.74%, 0.67%, and 0.85% for Q3 2021, Q2 2021, and Q1 2021 respectively.